![Zurit Levine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 111 331 $ al 31/07/2026
Zurit Levine currently works at Compugen Ltd., as Vice President-Technology Innovation from 2018.
Dr. Levine also formerly worked at Neviah Genomics Ltd., as Director.
Dr. Levine received her undergraduate degree, graduate degree, and doctorate degree from Tel-Aviv University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
COMPUGEN LTD. 0,05 % | 29/07/2026 | 47.375 ( 0,05 % ) | 111 331 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| COMPUGEN LTD. | Director Técnico/Científico/I+D | 01/01/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Neviah Genomics Ltd.
 Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel biomarkers for the prediction of drug-induced toxicity | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neviah Genomics Ltd.
Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Develops novel biomarkers for the prediction of drug-induced toxicity | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
